Trial Profile

Active surveillance with or without a 6 months Apalutamide treatment in low risk prostate cancer: a phase II randomized multicenter trial.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 24 Mar 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Apalutamide (Primary)
Indications Prostate cancer
Focus Therapeutic Use
Acronyms PC-ARN

Most Recent Events

20 Mar 2026 Status changed from recruiting to completed.
06 Jun 2023 Results (n=91) assessing anxiety and depression using the Hospital Anxiety and Depression Scale (HADS) and prostate-specific anxiety using the Memorial Anxiety Scale for Prostate Cancer , presented at the 59th Annual Meeting of the American Society of Clinical Oncology.
18 Feb 2023 Results assessing 1-year safety and quality of life analyses, presented at the 2023 Genitourinary Cancers Symposium.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com